Dr. Jack Kavanaugh

M.D., D.D.S. M.B.A.
Managing Member of General Partner

Jack Kavanaugh

A widely respected physician and business executive with an impressive array of business accomplishments. Successfully led companies at every stage – from inception to successful sale – creating industry-leading products and generating high returns for investors. Focused on the health and science technology sector, capitalizing on his background in medicine and business to lead M&A, turnarounds, and corporate strategic development and initiatives. Companies he has led have made a significant positive impact on society and the welfare of people everywhere.

Certain Key Accomplishments:

ZetaRx Biosciences:
• Founder, Chairman & CEO of the company.
• Sold to become the core of Juno Therapeutics, which later had the largest biotech IPO of 2014.
• Jan 2018, Celgene announced a $9 billion deal to puchase 90% of Juno.

Amerident:
• A health care service provider which he founded in 1996.
• Grew organically from 1 to approx. 600 employees.
• Sold at a significant multiple of invested capital to a public company approx two and a half years from inception, in 1999.
• Received over 30 community service awards and a state congressional medal of honor for its work with infants.

Calhoun Vision:
• Biotech firm developing the world’s first and only light adjustable intraocular lens for cataract surgery.
• Dr. Kavanaugh played a pivotal role in assisting Calhoun from inception at CalTech to commercialization abroad.
• Approved in Europe with a CE Mark and also in Mexico
• Led the company into the stages of US clinical trials, where its industry leading and disruptive product has completed all 600 patients in US Phase III (the final) clinical trials.
• Co-founder of Black Light Surgical, Inc., Fortem Neuroscience Inc., Hydrophilix, Inc., LongLifeRx, Inc., Nanotech Energy, Inc., Novonco Therapeutics Inc., is chairman of the board of directors of Arrogene, Inc., Black Light Surgical, Inc. (co-chairman), Fortem Neuroscience Inc. (co-chairman), Hydrophilix, Inc., LongLifeRx, Inc., Nanotech Energy, Inc., Novonco Therapeutics Inc., Orbsen Therapeutics, Ltd., SuperMetalix, Inc., Vault Nano Inc. dba Vault Pharma and Westwood Bioscience, Inc., is the chief executive officer or acting chief executive officer of SuperMetalix, Inc., Nanotech Energy, Inc. and Novonco Therapeutics Inc.